V Koulourida1, E Martziou1, K Tsergouli2, A Papa2. 1. 1 Department of Microbiology, Biochemistry and Virology, General Hospital Papageorgiou, Thessaloniki, Greece. 2. 1 Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Greece.
Abstract
BACKGROUND: Acinetobacter baumannii is responsible for a variety of nosocomial infections, especially in intensive care unit patients. Nosocomial outbreaks due to carbapenem-resistant A. baumannii strains have been reported in many countries, including Greece. The aim of the present study was to determine the trends of molecular epidemiology of carbapenem-resistant A. baumannii isolates in a 750-bed hospital in Thessaloniki, Greece, during 2009. METHODS: The study included 39 carbapenem-resistant A. baumannii isolates collected from patients hospitalized in the General Hospital Papageorgiou during 2009. They were tested for the presence of Ambler class D carbapenemases and class 1 integrons, and they were typed by pulsed-field gel electrophoresis. RESULTS: The bla OXA-58 gene was detected in all A. baumannii isolates. Among the 39 isolates, 18 were carrying a 2.2 kb integron, 18 were carrying a 2.5 kb integron, and 3 isolates had no class 1 integrons. Two different clones, each divided further into two subclones, were observed. Comparing the clones detected in 2009 with those of former years (2001- 2008), a significant difference was observed: three clones have disappeared, two clones continued to circulate in the hospital, while a new subclone emerged in February 2009. CONCLUSIONS: A change was seen in the molecular epidemiology of carbapenem-resistant A. baumannii isolates during 2009. Molecular epidemiology studies provide useful data for the distribution of resistant bacteria in order to design effective prevention and control measures.
BACKGROUND:Acinetobacter baumannii is responsible for a variety of nosocomial infections, especially in intensive care unit patients. Nosocomial outbreaks due to carbapenem-resistant A. baumannii strains have been reported in many countries, including Greece. The aim of the present study was to determine the trends of molecular epidemiology of carbapenem-resistant A. baumannii isolates in a 750-bed hospital in Thessaloniki, Greece, during 2009. METHODS: The study included 39 carbapenem-resistant A. baumannii isolates collected from patients hospitalized in the General Hospital Papageorgiou during 2009. They were tested for the presence of Ambler class D carbapenemases and class 1 integrons, and they were typed by pulsed-field gel electrophoresis. RESULTS: The bla OXA-58 gene was detected in all A. baumannii isolates. Among the 39 isolates, 18 were carrying a 2.2 kb integron, 18 were carrying a 2.5 kb integron, and 3 isolates had no class 1 integrons. Two different clones, each divided further into two subclones, were observed. Comparing the clones detected in 2009 with those of former years (2001- 2008), a significant difference was observed: three clones have disappeared, two clones continued to circulate in the hospital, while a new subclone emerged in February 2009. CONCLUSIONS: A change was seen in the molecular epidemiology of carbapenem-resistant A. baumannii isolates during 2009. Molecular epidemiology studies provide useful data for the distribution of resistant bacteria in order to design effective prevention and control measures.
Authors: S Pournaras; A Markogiannakis; A Ikonomidis; L Kondyli; K Bethimouti; A N Maniatis; N J Legakis; A Tsakris Journal: J Antimicrob Chemother Date: 2006-01-23 Impact factor: 5.790
Authors: Jane F Turton; Mary E Kaufmann; Judith Glover; Juliana M Coelho; Marina Warner; Rachel Pike; Tyrone L Pitt Journal: J Clin Microbiol Date: 2005-07 Impact factor: 5.948
Authors: F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan Journal: J Clin Microbiol Date: 1995-09 Impact factor: 5.948
Authors: A Tsakris; A Ikonomidis; A Poulou; N Spanakis; D Vrizas; M Diomidous; S Pournaras; F Markou Journal: Clin Microbiol Infect Date: 2008-04-05 Impact factor: 8.067